Envista Holdings Corp.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Envista Holdings Corp.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Last year, a total of 67 biopharma and medtech companies completed initial public offerings (IPOs), raising for $8.55bn between them.
- Consumables, Central Supplies
- Implantable Devices
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.